Celyad - Library

Clinical › Immuno-oncology June 17, 2019

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Posters June 15, 2019

Modeling NKG2D-based CAR-T cell therapy in animals with acute myeloid leukemia

Posters June 15, 2019

Development of a next generation allogeneic CAR-T cell platform without gene editing

Posters June 15, 2019

Updated results from Phase I trials assessing a NKG2D CAR T-cell approach in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome patients

Corporate › Non-regulated May 29, 2019

Celyad to Participate in Upcoming June 2019 Conferences

Corporate › Non-regulated May 16, 2019

Celyad to Present Data at 24th Congress of the European Hematology Association

Corporate › Regulated May 09, 2019

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Corporate › Non-regulated May 02, 2019

Celyad Announces May 2019 Investor Conference Schedule

Clinical › Immuno-oncology April 17, 2019

Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI Congress

Corporate › Non-regulated April 01, 2019

Celyad Announces April 2019 Investor Conference Schedule

Press releases March 29, 2019

Conference call Celyad full year 2018

Corporate › Regulated March 28, 2019

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results